111, Inc. (YI)
USD 8.4
(1.82%)
USD 8.4
(1.82%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 62.62 Million CNY | -37.67% |
| 2022 | 100.46 Million CNY | -39.34% |
| 2021 | 165.61 Million CNY | 165.46% |
| 2020 | 62.38 Million CNY | 9.43% |
| 2019 | 57.01 Million CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 56.17 Million CNY | 0.0% |
| 2024 Q1 | 54.67 Million CNY | 0.0% |
| 2023 Q3 | 64.81 Million CNY | -26.88% |
| 2023 FY | 62.62 Million CNY | -37.67% |
| 2023 Q1 | 85.91 Million CNY | -14.48% |
| 2023 Q4 | 62.62 Million CNY | -3.38% |
| 2023 Q2 | 88.63 Million CNY | 3.17% |
| 2022 Q1 | 152.64 Million CNY | -7.83% |
| 2022 Q4 | 100.46 Million CNY | -12.67% |
| 2022 FY | 100.46 Million CNY | -39.34% |
| 2022 Q2 | 128.99 Million CNY | -15.49% |
| 2022 Q3 | 115.04 Million CNY | -10.81% |
| 2021 Q4 | 165.61 Million CNY | 2.71% |
| 2021 FY | 165.61 Million CNY | 165.46% |
| 2021 Q3 | 161.24 Million CNY | -2.99% |
| 2021 Q2 | 166.22 Million CNY | 31.1% |
| 2021 Q1 | 126.79 Million CNY | 103.23% |
| 2020 Q4 | 62.38 Million CNY | 20.1% |
| 2020 Q2 | 54.54 Million CNY | -10.37% |
| 2020 FY | 62.38 Million CNY | 9.43% |
| 2020 Q1 | 60.84 Million CNY | 6.73% |
| 2020 Q3 | 51.94 Million CNY | -4.76% |
| 2019 Q3 | 58.37 Million CNY | 46.27% |
| 2019 Q2 | 39.91 Million CNY | -1.87% |
| 2019 Q1 | 40.67 Million CNY | 0.0% |
| 2019 Q4 | 57.01 Million CNY | -2.34% |
| 2019 FY | 57.01 Million CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | 19.93 Thousand USD | -314025.201% |
| China Jo-Jo Drugstores, Inc. | 6.4 Million USD | -877.911% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 183.17 Million USD | 65.811% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 183.17 Million USD | 65.811% |
| Leafly Holdings, Inc. | 29.08 Million USD | -115.314% |
| LifeMD, Inc. | 17.92 Million USD | -249.314% |
| LifeMD, Inc. | 17.92 Million USD | -249.314% |
| TRxADE HEALTH, Inc. | 434.2 Thousand USD | -14322.681% |
| PetMed Express, Inc. | 995 Thousand USD | -6193.869% |
| Walgreens Boots Alliance, Inc. | 8.04 Billion USD | 99.221% |